SoylentNews

Phoenix666 [soylentnews.org] writes:

A single-dose dengue vaccine [futurity.org], tested in a small clinical trial, was 100 percent effective in protecting human volunteers from a strain of the most prevalent mosquito-borne virus in the world.

The vaccine, developed at the National Institutes of Health, was tested in a trial led by researchers at the Johns Hopkins University Bloomberg School of Public Health and reported in the journal Science Translational Medicine [doi.org] .

It could represent a major advance in the battle against dengue, which infects nearly 400 million people across more than 120 countries each year. Most survive with few or no symptoms, but more than 2 million annually develop what can be a dangerous dengue hemorrhagic fever. That kills more than 25,000 people each year.

I've never had it, but have met enough survivors on my travels to know you'd never want to. Good news.

Original Submission